Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
An observational cohort study evaluating adalimumab concentrations for predicting non-recapture of biochemical response after dose escalation in patients with Crohn's disease experiencing secondary loss of response.
Journal: Journal of the Canadian Association of Gastroenterology
Published: June 05, 2026
R-AI-diographers: investigating the perceived impact of artificial intelligence on radiographers' careers, roles, and professional identity in the UK.
Journal: Frontiers in digital health
Published: March 31, 2025
Treatment patterns for advanced therapies in Canadians with moderate-to-severe inflammatory bowel disease: a retrospective cohort analysis.
Journal: Journal of the Canadian Association of Gastroenterology
Published: February 05, 2025
R-AI-diographers: a European survey on perceived impact of AI on professional identity, careers, and radiographers' roles.
Journal: Insights into imaging
Published: December 13, 2024
Cost-Effectiveness of Tight Control for Crohn's Disease With Adalimumab-Based Treatment: Economic Evaluation of the CALM Trial From a Canadian Perspective.
Journal: Journal of the Canadian Association of Gastroenterology
Published: August 03, 2022
Impact of adalimumab on disease burden in moderate-to-severe ulcerative colitis patients: The one-year, real-world UCanADA study.
Journal: World journal of gastroenterology
Published: March 30, 2022
Impact of Adalimumab Patient Support Program's Care Coach Calls on Clinical Outcomes in Patients with Crohn's Disease in Canada: An Observational Retrospective Cohort Study.
Journal: Journal of the Canadian Association of Gastroenterology
Published: July 12, 2019
Showing 1-7 of 7
Last Updated: 09/26/2026